Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

354 studies match

clinicaltrialsPublishedShowing 101–150 of 354 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07084896	Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM	active not recruiting	Phase 1 / Phase 2	106	GlaxoSmithKlineINDUSTRY	13	May 6, 2026	clinicaltrials
NCT04665843	A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck(SKYSCRAPER-09)	completed	Phase 2	123	Hoffmann-La RocheINDUSTRY